Wellgistics Advances Blockchain Strategy for Drug Supply Chain

Wellgistics Health, a healthcare information technology company listed on NASDAQ:WGRX, has announced progress in developing its blockchain-based pharmaceutical supply chain platform known as PharmacyChain. The company revealed that it has finalized the evaluation process to determine which blockchain technologies would best support the platform’s smart contract capabilities.

The initiative integrates the firm’s proprietary artificial intelligence system, EinsteinRx, with a blockchain-enabled smart contract framework designed to enhance efficiency and transparency in prescription drug distribution. Following a detailed review, the company identified several blockchain platforms as suitable foundations for building the system. These include Hyperledger Fabric, Ethereum combined with Polygon, VeChain, Quorum paired with Hyperledger Besu, and Corda.

According to the company, these technologies were selected because they provide the infrastructure necessary to build a pharmaceutical drug tracking system capable of meeting industry-wide serialization requirements. One of the key regulatory frameworks guiding this effort is the Drug Supply Chain Security Act, a U.S. regulation that mandates improved traceability across the pharmaceutical supply chain.

The organization stated that development work has already begun, with the initial goal of implementing the platform within its own pharmacy operations. Executives indicated that the company aims to complete the development of closed-loop data transfers that comply with Health Insurance Portability and Accountability Act standards. These secure data exchanges are required to support fully functional smart contracts. The firm expects this initial implementation to be completed by the end of the second quarter of 2026.

AI and Blockchain Integration for Pharmacy Operations

The company’s broader strategy involves using artificial intelligence and blockchain technologies to improve the prescription drug dispensing process. Through the integration of EinsteinRx with PharmacyChain, Wellgistics seeks to create a streamlined digital infrastructure for managing prescription fulfillment and pharmaceutical logistics.

Its existing platform currently connects more than 6,500 pharmacies through the Wellgistics Pharmacy Network while also working with more than 200 manufacturers. The integrated ecosystem provides services that include wholesale distribution, digital prescription routing, direct-to-patient medication delivery, and AI-powered support services.

These support services include patient eligibility verification, medication adherence monitoring, onboarding processes, prior authorization management, and cash-pay fulfillment. By consolidating these functions within a single system, the company aims to improve patient access to prescription drugs while supporting independent pharmacies operating in the United States.

Leadership Perspective and Future Adoption

Prashant Patel, president and interim chief executive officer of Wellgistics Health, indicated that the company had completed its assessment of blockchain technologies and identified the platforms it considered most suitable for building PharmacyChain. He explained that development efforts were now underway and that the organization expected to make the system operational within its own pharmacy by the following quarter.

Patel also suggested that the company planned to expand access to the technology across its network of more than 6,500 independent pharmacies later in the year. In addition, he indicated that other large participants in the pharmaceutical sector might eventually adopt similar blockchain-based solutions due to the company’s intellectual property position.

The executive further explained that the company intends to build several versions of PharmacyChain across different blockchain networks. This strategy is expected to encourage collaboration with pharmaceutical manufacturers, wholesalers, and pharmacies by enabling them to access the company’s patented technology to improve supply chain management systems. Patel added that the long-term vision involves establishing what the company describes as a digital health data infrastructure powered by tokenization and smart contracts. He also noted that the platform would be designed to allow other components of the healthcare ecosystem to integrate data seamlessly.

Market Potential for Blockchain in Healthcare

Wellgistics believes its intellectual property portfolio, which is exclusively licensed from Datavault AI, offers a competitive advantage in the implementation of smart contract technology within the healthcare sector.

Industry estimates suggest that the U.S. healthcare market represents approximately $4.9 trillion in economic activity. Research conducted by PwC indicates that around $1 trillion in healthcare spending could shift toward digital-first and personalized care models that reduce administrative complexity.

The blockchain segment within healthcare is also expected to grow significantly. Market analysis from Grand View Research estimates that the global blockchain healthcare market, currently valued at roughly $11 billion, could reach $214 billion by 2030 with annual growth rates exceeding 60 percent.

Meanwhile, the U.S. prescription drug market, which relies heavily on independent pharmacies, represents a $634 billion opportunity that is projected to expand to approximately $883 billion by the end of the decade. Analysts also anticipate strong growth in the healthcare-as-a-service sector, driven by the expanding use of cloud-based platforms across hospitals, clinics, and insurance providers.

By integrating blockchain, tokenized smart contracts, and artificial intelligence, Wellgistics aims to improve transparency and efficiency throughout the healthcare supply chain while ultimately supporting better patient outcomes.

The post Wellgistics Advances Blockchain Strategy for Drug Supply Chain appeared first on CoinTrust.